ARRIELLO GROUP LIMITED

Arriello Group Limited is a leading provider of integrated regulatory, pharmacovigilance, quality and compliance services for life-sciences companies. Drawing on deep scientific expertise, the firm guides clients through every stage of product development-from clinical-trial applications and marketing-authorisation submissions to post-approval safety monitoring and lifecycle management-ensuring seamless, on-time market entry across the EU, US, LATAM, MENA, CIS, APAC and South Africa.

The company's portfolio spans Clinical Safety, Pharmacovigilance (including EU-QPPV, LPPV, safety-data management, signal detection and medical writing), Regulatory Affairs (strategy, dossier development, submissions, intelligence and consulting) and Quality & Compliance (GxP auditing, technical consulting, risk management and quality-management systems). In addition, Arriello offers Local Affiliate Services, responsible-person support, and bespoke IT solutions for drug-safety databases, providing a single, trusted platform for global product launch and ongoing regulatory stewardship.

With a customer-centric approach and a network of over 128 audited partners, Arriello delivers scalable, pragmatic advice and operational capability, helping innovative pharmaceutical and biotech organisations accelerate development, reduce time-to-market and maintain rigorous compliance throughout the product lifecycle.